Inferra AIResearch Tools

Inferra AI / Company / CNC

Centene Corporation

CNC · Health Care

Last earnings Oct 27, 2026

Key results

Adjusted EPSquarter

$0.50

Adjusted Diluted Earnings Per Share of $0.50 --

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Revenuequarter

22%

2 Statement of Operations Three Months Ended September 30, 2025 For the third quarter of 2025, premium and service revenues increased 22% to $44.9 billion from $36.9 billion in the comparable period of 2024.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Adjusted diluted EPS of $0.50 for the third quarter of 2025.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

These payments are recorded as premium revenue and medical costs at close to a 100% HBR.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Additionally, approximately $106 million was recorded as a reduction to premium revenues resulting from development within Incurred related to Prior periods due to minimum HBR and other return of premium programs.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

AI analysis

Q3 2025 · reported Oct 29, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Adjusted EPS · Q3 2025
$0.50
EX-99 · Oct 29, 2025

Headline figures

MetricQ3 2025Prior qtrYear ago
Adjusted EPS$0.50——
Revenue22%——

EX-99 · Oct 29, 2025

Guidance · company-stated

Direction: Raised

EPS

“Increases 2025 full year adjusted diluted EPS forecast by $0.25 to at least $2.00.”

EPS

“The Company is updating its full year 2025 adjusted diluted EPS forecast to at least $2.00, an increase of $0.25 from the $1.75 forecast discussed on the July earnings call.”

Company outlook — Raised

“Our third quarter results and increased full year outlook demonstrate tangible progress against the near-term milestones we laid out for investors in July, said Chief Executive Officer of Centene, Sarah M.”

Classified from the release's primary full-year outlook statement.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.

Total debt was $17.6 billion, which included no borrowings on the $4.0 billion Revolving Credit Facility at quarter end.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Direction: Raised

EPS: “Increases 2025 full year adjusted diluted EPS forecast by $0.25 to at least $2.00.”

EPS: “The Company is updating its full year 2025 adjusted diluted EPS forecast to at least $2.00, an increase of $0.25 from the $1.75 forecast discussed on the July earnings call.”

EPS — Raised (“Increases”)
“Increases 2025 full year adjusted diluted EPS forecast by $0.25 to at least $2.00.”

Company outlook — Raised (“increased”)
“Our third quarter results and increased full year outlook demonstrate tangible progress against the near-term milestones we laid out for investors in July, said Chief Executive Officer of Centene, Sarah M.”

EPS — Raised (“increase”)
“The Company is updating its full year 2025 adjusted diluted EPS forecast to at least $2.00, an increase of $0.25 from the $1.75 forecast discussed on the July earnings call.”

Classified from the release's primary full-year outlook statement.

Capital allocation

After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Total debt was $17.6 billion, which included no borrowings on the $4.0 billion Revolving Credit Facility at quarter end.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Debt to Capitalization Ratio (GAAP) Total debt, divided by total debt plus total stockholder's equity.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

The proceeds from the sale were used for the partial redemption of the Company's Senior Notes due December 15, 2027.

SEC original ↗Centene Corporation — 10-Q Quarterly report10-QOct 27, 2026

Short-term and Long-term Investments, Restricted Deposits Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions): September 30, 2026 December 31, 2025 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Debt securities: U.

SEC original ↗Centene Corporation — 10-Q Quarterly report10-QOct 27, 2026

Accrued interest income on available-for-sale debt securities was $ 171 million and $ 180 million at September 30, 2026 and December 31, 2025, respectively, and is included in other current assets in the Consolidated Balance Sheets.

SEC original ↗Centene Corporation — 10-Q Quarterly report10-QOct 27, 2026

Strategy & priorities

While much work remains ahead, our organization remains focused on driving margin improvement, delivering outcomes for our members, and positioning the business for long-term success.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

In August, Managed Health Services, a Centene subsidiary, announced the list of organizations in Indiana selected to receive funding and programmatic support through MHS Serves' Youth Mental Health Empowerment Program , a partnership aimed at supporting the expansion and enhancement of programs, services and resources that directly address youth access to mental healthcare.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Risks & headwinds

By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions.

SEC original ↗Centene Corporation — Earnings release (8-K exhibit)EX-99Oct 29, 2025

Legal Proceedings 39 Item 1A.

SEC original ↗Centene Corporation — 10-Q Quarterly report10-QOct 27, 2026

"Legal Proceedings," and Part II, Item 1A.

SEC original ↗Centene Corporation — 10-Q Quarterly report10-QOct 27, 2026

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Gilead Sciences (GILD) Health CareGenmab (GMAB) Health CareAlcon (ALC) Health CareArgenx (ARGX) Health CareSanofi (SNY) Health CareMerck & Co. (MRK) Health CareXencor Inc (XNCR) Health CareIllumina, Inc. (ILMN) Health Care
Documents

Filings

61 documents

Earnings releases

16 documents

Presentations

0 documents

No presentations for Centene Corporation are held in this edition of the library.

Transcripts

0 documents

No transcripts for Centene Corporation are held in this edition of the library.

Mentioned by

5 companies

Other tracked companies whose held documents mention Centene Corporation by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.